Metastatic Colorectal Cancer
Metastatic Colorectal Cancer is a type of cancer that starts in the colon or rectum and spreads to other parts of the body. It can cause symptoms such as abdominal pain, changes in bowel habits, weight loss, and fatigue.
Metastatic Colorectal Cancer: Valproic Acid and Standard Treatment
We are studying a new combination of Valproic acid with standard therapies for patients with metastatic colorectal cancer who have already been treated. The goal is to see if this combination improves survival and quality of life compared to standard treatment alone.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have colorectal cancer that has spread to other parts of your body?
- Have you had any other cancer in the last five years, except for certain skin cancers?
- Are you currently pregnant or breastfeeding?
- Have you had major surgery in the last 4 weeks?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Campto
Canri
Chlorhydrate D'irinotécan Trihydraté Sun
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
AORN San Giuseppe Moscati Avellino
Medical Oncology
Avellino, Italy
Azienda Ospedaliera Sant'anna E San Sebastiano Di Caserta
Medical Oncology Unit
Caserta, Italy
Ospedale Civile San Giovanni di Dio - Frattamaggiore
Oncology
Frattamaggiore, Italy
Sponsor: IRCCS Istituto Nazionale Tumori Fondazione Pascale
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.